SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-032720
Filing Date
2021-06-16
Accepted
2021-06-16 16:18:21
Documents
5
Period of Report
2021-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea142779-8k_oramedpharma.htm 8-K 34032
2 EQUITY DISTRIBUTION AGREEMENT, DATED JUNE 16, 2021, BY AND BETWEEN THE COMPANY A ea142779ex1-1_oramedpharma.htm EX-1.1 235248
3 OPINION OF SULLIVAN & WORCESTER LLP ea142779ex5-1_oramedpharma.htm EX-5.1 8367
4 GRAPHIC ex5-1_001.jpg GRAPHIC 6157
5 GRAPHIC ex5-1_002.jpg GRAPHIC 1755
  Complete submission text file 0001213900-21-032720.txt   290161
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 211021727
SIC: 2834 Pharmaceutical Preparations